FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564751363> ?p ?o ?g. }

• W2564751363 abstract "Limb-girdle muscular dystrophy type 2E (LGMD2E) results from mutations in the beta-sarcoglycan (SGCB) gene causing loss of a sarcolemmal structural protein component of the dystrophin-associated protein complex (DAPC). This leads to a progressive dystrophy with numerous histopathological features, resulting in deteriorating muscle function. This occurs not only in limb muscle but also in the diaphragm and the heart. Consequences include respiratory failure and cardiomyopathy in 50% or more of LGMD2E patients. SGCB knockout mice share many of the phenotypic deficiencies of LGMD2E patients. In this mouse model we quantified dystrophic histopathology, fibrosis, and functional outcomes in lower limb, upper limb, and torso skeletal muscles, as well as the diaphragm and cardiac muscles. Diaphragms of SGCB-/- mice demonstrated reduced specific force output (116.24 mN/mm2) compared to wild-type (WT) mice (236.67 mN/mm2), and hearts from SGCB-/- mice had lower ejection fraction (58.19%) compared to WT mice (75.04%) as determined by MRI. Additionally, radiographic imaging defined the degree of kyphoscoliosis in SGCB-/- mice. Laser monitoring of open-field cage activity showed a reduction of ~55% in both total ambulation as well as hindlimb vertical rearing in SGCB-/- mice compared to WT. For treatment, we designed a self-complementary AAVrh74 vector containing a codon optimized human SGCB transgene driven by a muscle specific promoter. We next demonstrated efficacy of vector delivery by intramuscular (IM) injection to the tibialis anterior muscle, as well as isolated-limb perfusion (ILP) to the lower limb muscles of SGCB-/- mice. Along with restoration of SGCB expression in treated muscle, we saw histological and functional improvements and a reduction in fibrosis as indicated by reduced collagen deposition. These regional gene delivery studies were followed by systemic delivery of scAAV.hSGCB through the tail vein of SGCB-/- mice to provide a potential rationale for gene delivery in clinical trial that would lead to clinically meaningful results. Tail vein injection of scAAV.hSGCB resulted in nearly 100% transgene expression in numerous muscles throughout the hindlimbs, forelimbs, torso, and the heart, that was accompanied by improvements in histopathology including reduction in central nucleation and increased fiber diameter. Kyphoscoliosis of the spine was also improved, and total ambulation increased in scAAV.hSGCB treated mice by ~22% while hindlimb vertical rearing increased by ~77% in treated mice compared to KO. We also saw complete restoration of diaphragm function following treatment with specific force output improved to 226.07 mN/mm2. In this well-defined mode of LGMD2E, we have demonstrated that systemic delivery of scAAV.hSGCB normalizes histologic and functional outcome measures in limb, diaphragm, and heart. These findings have established a path for AAV mediated gene therapy for LGMD2E that we are currently pursuing." @default.
• W2564751363 created "2017-01-06" @default.
• W2564751363 creator A5004265952 @default.
• W2564751363 creator A5011967982 @default.
• W2564751363 creator A5023347371 @default.
• W2564751363 creator A5047809221 @default.
• W2564751363 creator A5053075028 @default.
• W2564751363 date "2016-05-01" @default.
• W2564751363 modified "2023-09-22" @default.
• W2564751363 title "622. Systemic β-Sarcoglycan Gene Therapy for Treatment of Cardiac and Skeletal Muscle Deficits in LGMD2E" @default.
• W2564751363 doi "https://doi.org/10.1016/s1525-0016(16)33430-x" @default.
• W2564751363 hasPublicationYear "2016" @default.
• W2564751363 type Work @default.
• W2564751363 sameAs 2564751363 @default.
• W2564751363 citedByCount "0" @default.
• W2564751363 crossrefType "journal-article" @default.
• W2564751363 hasAuthorship W2564751363A5004265952 @default.
• W2564751363 hasAuthorship W2564751363A5011967982 @default.
• W2564751363 hasAuthorship W2564751363A5023347371 @default.
• W2564751363 hasAuthorship W2564751363A5047809221 @default.
• W2564751363 hasAuthorship W2564751363A5053075028 @default.
• W2564751363 hasBestOaLocation W25647513631 @default.
• W2564751363 hasConcept C104317684 @default.
• W2564751363 hasConcept C105702510 @default.
• W2564751363 hasConcept C111599444 @default.
• W2564751363 hasConcept C126322002 @default.
• W2564751363 hasConcept C134018914 @default.
• W2564751363 hasConcept C142724271 @default.
• W2564751363 hasConcept C2777017193 @default.
• W2564751363 hasConcept C2778198053 @default.
• W2564751363 hasConcept C2778797674 @default.
• W2564751363 hasConcept C2778943923 @default.
• W2564751363 hasConcept C2779030066 @default.
• W2564751363 hasConcept C2779959927 @default.
• W2564751363 hasConcept C2780394045 @default.
• W2564751363 hasConcept C51738704 @default.
• W2564751363 hasConcept C55493867 @default.
• W2564751363 hasConcept C71924100 @default.
• W2564751363 hasConcept C86803240 @default.
• W2564751363 hasConceptScore W2564751363C104317684 @default.
• W2564751363 hasConceptScore W2564751363C105702510 @default.
• W2564751363 hasConceptScore W2564751363C111599444 @default.
• W2564751363 hasConceptScore W2564751363C126322002 @default.
• W2564751363 hasConceptScore W2564751363C134018914 @default.
• W2564751363 hasConceptScore W2564751363C142724271 @default.
• W2564751363 hasConceptScore W2564751363C2777017193 @default.
• W2564751363 hasConceptScore W2564751363C2778198053 @default.
• W2564751363 hasConceptScore W2564751363C2778797674 @default.
• W2564751363 hasConceptScore W2564751363C2778943923 @default.
• W2564751363 hasConceptScore W2564751363C2779030066 @default.
• W2564751363 hasConceptScore W2564751363C2779959927 @default.
• W2564751363 hasConceptScore W2564751363C2780394045 @default.
• W2564751363 hasConceptScore W2564751363C51738704 @default.
• W2564751363 hasConceptScore W2564751363C55493867 @default.
• W2564751363 hasConceptScore W2564751363C71924100 @default.
• W2564751363 hasConceptScore W2564751363C86803240 @default.
• W2564751363 hasLocation W25647513631 @default.
• W2564751363 hasOpenAccess W2564751363 @default.
• W2564751363 hasPrimaryLocation W25647513631 @default.
• W2564751363 hasRelatedWork W1593354458 @default.
• W2564751363 hasRelatedWork W1613284930 @default.
• W2564751363 hasRelatedWork W1968351987 @default.
• W2564751363 hasRelatedWork W1969224887 @default.
• W2564751363 hasRelatedWork W197892370 @default.
• W2564751363 hasRelatedWork W1993671609 @default.
• W2564751363 hasRelatedWork W2026987421 @default.
• W2564751363 hasRelatedWork W2034178926 @default.
• W2564751363 hasRelatedWork W2073897762 @default.
• W2564751363 hasRelatedWork W2082116323 @default.
• W2564751363 hasRelatedWork W2110093084 @default.
• W2564751363 hasRelatedWork W2274904340 @default.
• W2564751363 hasRelatedWork W2561804023 @default.
• W2564751363 hasRelatedWork W2562416135 @default.
• W2564751363 hasRelatedWork W2592994478 @default.
• W2564751363 hasRelatedWork W2742673766 @default.
• W2564751363 hasRelatedWork W2766268399 @default.
• W2564751363 hasRelatedWork W2990403252 @default.
• W2564751363 hasRelatedWork W3171575192 @default.
• W2564751363 hasRelatedWork W3176518538 @default.
• W2564751363 isParatext "false" @default.
• W2564751363 isRetracted "false" @default.
• W2564751363 magId "2564751363" @default.
• W2564751363 workType "article" @default.